# Amino Sequence Review 2026: Research Peptides, GLP Compounds & Longevity Agents
For research purposes only. All compounds discussed are sold exclusively for laboratory and in-vitro scientific research and are not intended for human or veterinary use.
If you are searching for an Amino Sequence review, you have landed in the right place. This 2026 evaluation covers the company's full research catalog listed on Peptides.SO, including its specialty compound positioning, pricing, and overall profile as a domestic research supplier.
Overview
Amino Sequence is a U.S.-based research compound supplier with 30 active listings on Peptides.SO. The company's catalog reflects broad multi-category positioning, with particularly strong representation in GLP receptor agonist compounds, tissue healing peptides, anti-aging and longevity research agents, cognitive peptides, and NAD+ formulations.
What distinguishes Amino Sequence from many comparable vendors is its catalog depth in combination formulations and frontier compound classes. The presence of FOXO4-DRI — a stapled peptide researched in cellular senescence biology — signals a supplier positioning toward more specialized longevity research audiences rather than general-market buyers.
The company's website is aminosequence.com, and it accepts cryptocurrency as a payment method, which is a notable feature for researchers who prefer pseudonymous transactions.
Star Rating: 4.0 / 5.0
Product Quality
Amino Sequence's product quality profile is characterized by its coverage of highly specialized research tools. The catalog spans:
- •GLP Receptor Research Compounds: The GLP lineup is among the most complete in the mid-market supplier tier. GLP-1 (Semaglutide, 5mg–20mg in multiple sizes), GLP-2 (Tirzepatide), and GLP3 (Retatrutide) provide the full contemporary triad of incretin receptor agonist compounds for researchers studying GLP-1R, GLP-1R/GIPR, and GLP-1R/GIPR/GCGR biology respectively. The addition of CagriSema 10mg/10mg (Cagrilintide + Semaglutide combination) and CagriTirz 20mg (Cagrilintide + Tirzepatide) addresses the emerging research territory of amylin/GLP-1 co-agonism — a pharmacologically active area in metabolic syndrome and body composition research.
- •FOXO4-DRI: This is a genuinely differentiated catalog entry. FOXO4-DRI is a stapled peptide engineered to interfere with the FOXO4–p53 protein interaction in senescent cells, studied for its ability to selectively trigger apoptosis in senescent cells rather than healthy cells. Its presence in the catalog identifies Amino Sequence as one of the few mid-market vendors offering this compound, positioning them squarely toward longevity biology and cellular senescence research audiences.
- •Tissue Repair Coverage: BPC-157 and TB-500 are both available individually and as a 10mg/10mg blend in 10-vial kits, serving synergistic healing biology study designs. BPC-157 has been documented in preclinical models of gastrointestinal mucosal healing, tendon repair, ligament regeneration, and anti-inflammatory signaling cascades. TB-500 (Thymosin Beta-4) is researched in actin dynamics, wound healing, and cardiac tissue repair models.
- •Anti-Aging and Longevity Segment: Epithalon (tetrapeptide Ala-Glu-Asp-Gly) is available in both standard vial format and a pre-mixed pen format (100mg), serving different research dosing protocols. SS-Mito (50mg) is a mitochondrial-targeting peptide relevant to bioenergetics research. GHK-Cu in bulk powder form (100mg) provides one of the lower-cost per-mg entries in this compound class across the research supplier market.
- •GH-Axis and Cognitive Coverage: The CJC/Ipamorelin Blend addresses pulsatile GHRH/GHRP combination research. Tesamorelin/Ipamorelin combination covers GHRH analog + GHRP dual-compound study designs. Selank and Semax address anxiolytic and neuroprotective research. MOTS-c supports mitochondrial biology and metabolic adaptation studies.
- •Novel Compound Diversity: SLU-PP-332 covers ERR agonist exercise-mimetic pharmacology research. NAD+ and 5-Amino-1MQ address nicotinamide metabolism and cellular energy research. SS-Mito 50mg provides a specialty mitochondrial peptide option.
Testing Standards
Amino Sequence does not currently display third-party certificates of analysis (CoA) or verification badges on its Peptides.SO profile. The testing score on file is 0, which means that independent documentation of compound identity and purity has not been submitted through the platform's verification pathway.
For any research procurement, independent verification of compound identity and purity is essential regardless of supplier profile status. Researchers sourcing compounds from any vendor should request lot-specific CoA documentation — including HPLC purity data and mass spectrometry identity confirmation — before use in any experimental protocol. The absence of a displayed testing score is common across the mid-market supplier tier and does not by itself indicate product quality issues, but researchers should factor this into their sourcing decisions alongside direct communication with the supplier.
Pricing & Selection
Amino Sequence's verified per-milligram pricing for available listings reflects competitive positioning within the mid-market tier:
- •GHK-Cu Bulk Powder (100mg): Approximately $0.55/mg — among the lowest price points for this compound across comparable research vendors on Peptides.SO
- •KLOW Blend (80mg): $1.19–$1.44/mg depending on format, offering a multi-compound healing combination at a reasonable per-mg rate
- •SS-Mito (50mg): $2.90/mg for this specialty mitochondrial peptide
- •BPC-157 (gift-with-purchase listing, 10mg): ~$6.00/mg
- •CagriTirz (20mg): $6.75/mg for the Cagrilintide/Tirzepatide combination format
The GHK-Cu bulk powder pricing is particularly notable as a competitive differentiator. Combination formulation availability (CagriSema, CagriTirz, GLP3/CAGRI 20mg/4mg) provides researchers with pre-combined options that simplify multi-compound study logistics.
With 30 active listings, Amino Sequence sits at the top of the listing count range for this batch of suppliers. The catalog breadth covers research from GLP receptor agonism through longevity biology, tissue repair, cognitive neuroprotection, and mitochondrial function — a genuinely wide research mandate satisfied by a single vendor relationship.
Customer Experience
Amino Sequence accepts cryptocurrency as a payment method — a notable differentiator for researchers who prefer privacy-preserving payment options. The company's website at aminosequence.com is the primary resource for current product availability, pricing, and procurement procedures.
The company's 30-listing footprint on Peptides.SO enables researchers to use the platform's comparison tools to identify pricing and availability relative to other vendors carrying the same compound. No discount codes or promotional pricing are currently displayed on the platform profile.
The catalog's combination formulation depth (five GLP/Cagrilintide combination formats across the range) reduces the need for multi-vendor sourcing for researchers designing multi-compound metabolic biology studies.
Pros & Cons
Pros:
- •Largest listing count in this batch (30 compounds), providing single-vendor research convenience
- •Unique FOXO4-DRI availability positions the company in frontier longevity biology research
- •Full GLP receptor triad coverage including multiple combination formats (CagriSema, CagriTirz)
- •Competitive GHK-Cu bulk powder pricing (~$0.55/mg)
- •Cryptocurrency payment acceptance for privacy-conscious researchers
- •Bulk Epithalon availability in pre-mixed pen format for extended study designs
- •NAD+, 5-Amino-1MQ, and SLU-PP-332 extend coverage into metabolic/energy research
Cons:
- •No third-party testing documentation visible on platform profile
- •Location listed as "Unknown" — domestic vs. international origin unconfirmed
- •No discount codes or promotional pricing currently displayed
- •Standard CoA documentation should be requested directly from supplier before any use
Verdict
Amino Sequence earns a 4.0/5.0 in this 2026 evaluation. The company's 30-compound catalog is one of the most comprehensive in this batch, and the inclusion of FOXO4-DRI alongside a full range of GLP combination formats sets the supplier apart from generic catalog vendors. The competitive GHK-Cu bulk pricing and cryptocurrency payment acceptance are additional positive differentiators.
The absence of third-party testing documentation on the platform profile is the primary area for improvement. Researchers who prioritize transparency through published CoA documentation should request this directly from the supplier before procurement.
For researchers seeking a broadly capable domestic vendor with strong representation in GLP biology, longevity research compounds, and combination formulations, Amino Sequence represents a credible sourcing option worth evaluating.
This review is published for informational and research purposes only. Peptides.SO does not endorse any specific supplier and encourages researchers to conduct independent due diligence before procurement.